Processa Pharmaceuticals, Inc. has filed a prospectus supplement allowing the sale of $5,239,073 worth of common stock through its equity distribution agreement with A.G.P. / Alliance Global Partners. In the past 12 months, the company has already sold $1,546,338 worth of shares, leaving $3,692,735 available for future sales. The document does not specify the price per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.